Keyphrases
Tumor
47%
In Cancer
41%
Variant Interpretation
32%
Neoantigen
29%
RNA Sequencing (RNA-seq)
27%
Clinical Interpretation
24%
Somatic mutation
22%
Somatic Variants
22%
Neoadjuvant
21%
Acute Myeloid Leukemia
18%
Cancer Variants
17%
Interaction Database
17%
Drug-gene Interaction
17%
Whole Genome Sequencing
14%
Neoantigen Prediction
14%
Follicular Lymphoma
13%
Clinical Genome Resource
13%
Genomic Data
13%
Curation
12%
Clonal Architecture
12%
Genomic Landscape
11%
Breast Cancer
11%
Community-based
10%
Crowdsourcing
10%
Phase II Trial
10%
Transcriptome
10%
Triple-negative Breast Cancer
10%
Cancer Genomics
10%
Natural Killer Cells
10%
ER+ Breast Cancer
10%
Pathological Complete Response
9%
Transcriptome Analysis
9%
Clinically Significant
9%
Complementary DNA (cDNA)
9%
Patient-derived Xenograft
9%
Melanoma
9%
Whole Exome Sequencing
9%
Mutational Landscape
9%
Genome Analysis
8%
Sequence Data
8%
Head-and-neck Cancer
8%
Exon
8%
Microglia
8%
Standard Operating Procedures
8%
Massively Parallel Sequencing
8%
Clinical Trials
8%
Cancer Patients
8%
Driver mutations
8%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
7%
Bioinformatics Methods
7%
Biochemistry, Genetics and Molecular Biology
Genomics
100%
RNA Sequencing
29%
Somatic Mutation
25%
Transcriptome
22%
RNA Sequence
18%
Deep Sequencing
18%
Cancer Cell
17%
RNA
17%
Gene Interaction
17%
T Cell
16%
Exome
16%
Exome Sequencing
14%
Germ Cell
14%
Germline
14%
Genetics
12%
Myeloid
12%
Whole Genome Sequencing
12%
Molecular Cloning
12%
Isoform
11%
Genome Sequencing
11%
Exon
10%
Clinical Trial
10%
Immunity
9%
Alternative Splicing
9%
Messenger RNA
9%
Medline
8%
B Cell
8%
Peptide Sequence
8%
Binding Site
8%
Gene Fusion
8%
Gene Expression Profiling
8%
Kinase
8%
Phosphotransferase
8%
Allele
7%
Transcription
7%
MicroRNA
6%
Fluorouracil
6%
Open Reading Frame
6%
Drug Resistance
6%
Transcription Factors
6%
Cancer Immunotherapy
6%
Mutated Genes
6%
Exome Sequencing
5%
Gene Mutation
5%
Gene Frequency
5%
KRAS
5%
Reverse Transcription Polymerase Chain Reaction
5%
Human Genome
5%
Gene Amplification
5%
Drug Response
5%
Medicine and Dentistry
Neoplasm
48%
Malignant Neoplasm
46%
Somatics
22%
Breast Cancer
19%
Exome Sequencing
16%
Natural Killer Cell
14%
Follicular Lymphoma
13%
Somatic Mutation
13%
Medicine
12%
Acute Myeloid Leukemia
11%
Genome Sequencing
10%
Phase II Trials
10%
RNA Sequencing
9%
Clinical Trial
7%
Non-Hodgkin Lymphoma
7%
Clinical Stage
7%
Disease
7%
Immunity
7%
Hematopoietic Cell
6%
T Cell
6%
Triple Negative Breast Cancer
6%
Head and Neck Cancer
6%
Pembrolizumab
6%
Diffuse Large B-Cell Lymphoma
6%
Anastrozole
6%
Oncology
6%
Treatment Response
6%
RNA Sequence
5%
Breast Cancer Cell Line
5%
Clinical Significance
5%
Tumor Progression
5%
